Text messages and letters aim to bring young cancer survivors back to the doctor

NCT ID NCT07138040

Recruiting now Knowledge-focused Sponsor: Children's Hospital of Philadelphia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether simple digital tools—like letters and text messages—can encourage adolescent and young adult survivors of childhood cancer to schedule and attend long-term follow-up appointments. About 530 participants who are overdue for care will receive different combinations of these nudges. The goal is to find the best way to re-engage them in monitoring for late effects of their cancer treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: digital behavioral interventions (written information and text messages)
What this could lead to: If successful, this could show simple digital tools help young cancer survivors get back to needed follow-up care, improving long-term health.
What could go wrong: This is a behavioral study, not a drug trial. It tests whether reminders and information work, not a cure. Results may vary by individual and setting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer childhood malignant neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER

Contacts and locations

Locations

Children's Hospital of Philadelphia
RECRUITING

Philadelphia, Pennsylvania, 19104, United States
Nationwide Children's Hospital
RECRUITING

Columbus, Ohio, 43205, United States
Penn Medicine
RECRUITING

Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.